FTM testosterone therapy: what the science says about early changes
Quick answer
Testosterone therapy in transmasculine individuals produces laryngeal growth and vocal fold thickening, leading to measurable reductions in fundamental speaking frequency typically within the first three to six months, as documented across multiple acoustic studies. Individual outcomes vary considerably based on baseline anatomy, testosterone levels achieved, duration of therapy, and concurrent voice training. Voice changes are among the earliest masculinizing effects and are generally considered permanent once established.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @mitch.james actually say?
This video is a voice diary. Mitch recorded the same phrase, "Hi, my name is Mitch," every month for a year on testosterone, letting the audio document the progression from one day on T through twelve months. There are no explicit medical claims here. No dosages, no promises, no comparisons. Just a year of voice samples stitched together.
That restraint matters. The video is functioning as personal documentation, not medical advice. The caption says things changed "for the better," which is a subjective statement about personal experience, not a clinical assertion. Still, 881,000 views means a lot of people are drawing conclusions from this, so it's worth examining what the science actually says about what we're hearing.
Does the science back this up?
Yes, and fairly robustly. The pattern shown here, gradual voice deepening across the first year of testosterone therapy, is one of the most well-documented effects of masculinizing hormone therapy. A 2016 study by Azul et al. in the Journal of Voice found that fundamental frequency (the acoustic measure of pitch) decreases significantly within the first few months of testosterone therapy, with changes continuing across the first year and sometimes beyond.
More specifically, Deuster et al. (2016, Journal of Voice) tracked trans masculine patients and found mean speaking fundamental frequency dropped from roughly 196 Hz at baseline to around 120 Hz after six months of testosterone, approaching typical male ranges. The video appears consistent with that trajectory. The voice audibly drops in the early months, plateaus somewhat, then continues shifting. This is not anecdote. It's a documented physiological process driven by laryngeal growth and vocal fold thickening in response to androgens.
What did they get wrong (or right)?
Mitch gets the implied claim right: voice does change progressively over the first year on testosterone. There are no factual errors here because there are almost no explicit factual claims. The video earns credit for that discipline.
What's missing, though, is context that viewers probably need. Voice change is not uniform. Ziegler et al. (2018, Journal of Voice) found significant individual variation in vocal outcomes among transmasculine people on testosterone, with some individuals experiencing more modest changes, voice instability, or pitch breaks that the video doesn't capture. The viewer watching this might assume their own experience will mirror Mitch's timeline. It might not.
There's also no mention that voice training alongside HRT, as explored by Davies and Johnston (2015, Perspectives on Voice and Voice Disorders), can improve vocal quality, resonance, and consistency in ways that testosterone alone does not guarantee. The video shows one person's trajectory. It shouldn't be read as a template.
What should you actually know?
If you're starting testosterone or considering it, here's what the evidence actually supports:
- Voice deepening is one of the earliest and most consistent effects of testosterone therapy in transmasculine individuals, typically beginning within weeks to a few months of starting treatment.
- The process is gradual and variable. Not everyone's voice will change at the same rate or to the same degree.
- Voice changes from testosterone are generally considered irreversible once they occur, which is clinically significant for anyone weighing this decision.
- Working with a speech-language pathologist during HRT can optimize vocal outcomes beyond what testosterone alone produces.
- If your voice feels unstable or you experience pain when speaking during the early months of T, that's common and worth discussing with a provider, not ignoring.
This video is a compelling personal record. Use it as inspiration if that's useful. Don't use it as a clinical prediction of your own timeline.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For FTM testosterone therapy: what the science says about early changes, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Understanding weight gain at menopause
Background source for body-composition and weight-change discussions around menopause.
PubMed
Management of obesity in menopause
Current source for menopause-specific obesity management framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
FTM testosterone therapy: what the science says about early changes should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone therapy in transmasculine individuals produces laryngeal growth and vocal fold thickening, leading to measurable reductions in fundamental speaking frequency typically within the first three to six months, as documented across multiple acoustic studies.
FormBlends verdict
Testosterone therapy in transmasculine individuals produces laryngeal growth and vocal fold thickening, leading to measurable reductions in fundamental speaking frequency typically within the first three to six months, as documented across multiple acoustic studies. Individual outcomes vary considerably based on baseline anatomy, testosterone levels achieved, duration of therapy, and concurrent voice training. Voice changes are among the earliest masculinizing effects and are generally considered permanent once established.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone therapy in transmasculine individuals produces laryngeal growth and vocal fold thickening, leading to measurable reductions in fundamental speaking frequency typically within the first three to six months, as documented across multiple acoustic studies. Individual outcomes vary considerably based on baseline anatomy, testosterone levels achieved, duration of therapy, and concurrent voice training. Voice changes are among the earliest masculinizing effects and are generally considered permanent once established.
- Deuster et al. (2016, Journal of Voice) found mean speaking pitch dropped from ~196 Hz to ~120 Hz in transmasculine patients after six months of testosterone therapy.
- Voice changes typically begin within weeks to a few months of starting testosterone, making it one of the earliest observable effects of masculinizing HRT.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Deuster et al. (2016, Journal of Voice) found mean speaking pitch dropped from ~196 Hz to ~120 Hz in transmasculine patients after six months of testosterone therapy.
- Voice changes typically begin within weeks to a few months of starting testosterone, making it one of the earliest observable effects of masculinizing HRT.
- Ziegler et al. (2018, Journal of Voice) documented significant individual variation, meaning one person's year-long timeline is not a reliable predictor of another's experience.
- Testosterone-induced voice changes are generally considered irreversible, a fact worth understanding before starting therapy.
- Voice training with a speech-language pathologist can improve resonance and vocal quality in ways that testosterone alone does not guarantee, per Davies and Johnston (2015).
- Pitch breaks and vocal instability during the early months of testosterone are common and documented, not signs that something is wrong.
- This video shows one individual's trajectory across twelve months. It is personal documentation, not a clinical protocol or guaranteed outcome.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Mitchel Haden · TikTok creator
881.1K views on this video
I can’t believe I’ve already made it this far on T! So much has changed and for the better! #hrt #testosterone #ftm #trans
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Not medical advice. This video was made by Mitchel Haden, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.